MakeMyTrip Ltd vs Synchrony Financial — how do they compare? MakeMyTrip Ltd trades at $44.73 (market cap $4.09B), while Synchrony Financial trades at $72.8 (market cap $23.99B). The key difference: Synchrony Financial is far larger — about 5.9× MakeMyTrip Ltd's market cap, and Synchrony Financial pays a 1.84% dividend while MakeMyTrip Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold MakeMyTrip Ltd for 12 Days and Synchrony Financial for 29 Days on average.
| MMYT | SYF | |
|---|---|---|
Market Cap | $4.09B | $23.99B |
Volume | 1,828,010 | 3,813,027 |
Sector | Consumer Cyclical | Financials |
52-Week High | $94.43 | $88.47 |
52-Week Low | $36.30 | $63.78 |
Typical Hold Time | 12 Days | 29 Days |
Enterprise Value | $4.75B | $24.23B |
Dividend Yield | — | 1.84% |
Signals from Pluang's Aura AI — not financial advice
MMYT trades at $44.73, up 3.04% today, but technical indicators signal a bearish trend with support at $42. The stock shows mixed earnings, missing Q4 2025 and Q2 2026 estimates but beating Q1 2026. Revenue grew to $978.34M in 2025, though net income margin is thin at 3.23%. Analyst consensus is strongly bullish with a $77 price target, but cash flow turned negative in 2026, and debt-to-asset ratio surged, raising financial stability concerns.
The outlook is bifurcated: strong analyst support and a high target suggest upside, but deteriorating cash flow, rising leverage, and bearish technicals pose significant risks. Investors should weigh the potential from operational resilience and a planned Indian listing against financial volatility and macroeconomic pressures on travel demand.
Synchrony Financial (SYF) trades at $72.80, up 1.21% on the day, with a bullish technical signal despite some bearish moving average indicators. The company demonstrates strong fundamentals with a low P/E ratio of 7.56 and robust profitability, including a 23.4% net income margin and 22.23% ROE. Recent earnings have consistently beaten estimates, and positive news includes a partnership with OpenAI and expansion of its CareCredit platform.
The outlook is positive, supported by strong analyst consensus with a $87.58 price target and a 'Moderate Buy' rating. Key opportunities include attractive valuation and strategic partnerships, while risks involve increased investing outflows leading to negative net cash flow in 2026 and potential economic sensitivity affecting credit performance.
Trailing returns across standard periods
Latest headlines on both assets
MakeMyTrip Ltd. is a leading online travel company in India, providing a comprehensive range of travel services and products, including air tickets, hotels, holiday packages, rail tickets, and bus tickets. The company operates its primary websites and mobile apps under the brands MakeMyTrip, Goibibo, and RedBus. MMYT serves as a key intermediary in India's fragmented travel market, leveraging its platform to offer convenience and competitive pricing to consumers and businesses.
Read more on MMYT →Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →